Literature DB >> 26762449

Cachexia: Treat wasting illness on multiple fronts.

Kenneth Fearon1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26762449     DOI: 10.1038/529156b

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Cachexia: The last illness.

Authors:  Corie Lok
Journal:  Nature       Date:  2015-12-10       Impact factor: 49.962

2.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

3.  Request for regulatory guidance for cancer cachexia intervention trials.

Authors:  Kch Fearon; J M Argiles; V E Baracos; R Bernabei; Ajs Coats; J Crawford; N E Deutz; W Doehner; W J Evans; L Ferrucci; J M Garcia; R J Gralla; A Jatoi; K Kalantar-Zadeh; M Lainscak; J E Morley; M Muscaritoli; M I Polkey; G Rosano; F Rossi-Fanelli; A M Schols; F Strasser; B Vellas; S von Haehling; S D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-11       Impact factor: 12.910

  3 in total
  8 in total

1.  Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.

Authors:  Thomas A Blackwell; Igor Cervenka; Bhuwan Khatri; Jacob L Brown; Megan E Rosa-Caldwell; David E Lee; Richard A Perry; Lemuel A Brown; Wesley S Haynie; Michael P Wiggs; Walter G Bottje; Tyrone A Washington; Byungwhi C Kong; Jorge L Ruas; Nicholas P Greene
Journal:  Physiol Genomics       Date:  2018-10-05       Impact factor: 3.107

2.  Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.

Authors:  Jacob L Brown; Megan E Rosa-Caldwell; David E Lee; Thomas A Blackwell; Lemuel A Brown; Richard A Perry; Wesley S Haynie; Justin P Hardee; James A Carson; Michael P Wiggs; Tyrone A Washington; Nicholas P Greene
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-08-28       Impact factor: 12.910

3.  Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.

Authors:  Guohua Zhang; Zhelong Liu; Hui Ding; Hongyu Miao; Jose M Garcia; Yi-Ping Li
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

Review 4.  Practical multimodal care for cancer cachexia.

Authors:  Matthew Maddocks; Jane Hopkinson; John Conibear; Annie Reeves; Clare Shaw; Ken C H Fearon
Journal:  Curr Opin Support Palliat Care       Date:  2016-12       Impact factor: 2.302

5.  Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.

Authors:  Jacob L Brown; David E Lee; Megan E Rosa-Caldwell; Lemuel A Brown; Richard A Perry; Wesley S Haynie; Kendra Huseman; Kavithalakshmi Sataranatarajan; Holly Van Remmen; Tyrone A Washington; Michael P Wiggs; Nicholas P Greene
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-16       Impact factor: 12.910

6.  Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome.

Authors:  Felipe Henriques; Magno A Lopes; Felipe O Franco; Pamela Knobl; Kaltinaitis B Santos; Luana L Bueno; Victor A Correa; Alexander H Bedard; Adilson Guilherme; Alexander Birbrair; Sidney B Peres; Stephen R Farmer; Miguel L Batista
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

7.  Wnt7a Counteracts Cancer Cachexia.

Authors:  Manuel Schmidt; Christine Poser; Julia von Maltzahn
Journal:  Mol Ther Oncolytics       Date:  2020-01-11       Impact factor: 7.200

8.  Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.

Authors:  Hannes Zwickl; Elisabeth Zwickl-Traxler; Martin Pecherstorfer
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.